180 Life Sciences Corp.

NASDAQ: ATNF · Real-Time Price · USD
7.09
-0.52 (-6.83%)
At close: Aug 15, 2025, 3:59 PM
7.20
1.55%
After-hours: Aug 15, 2025, 07:58 PM EDT

180 Life Sciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-1.73M -2.37M -4.27M -836.72K 11.78K -1.07M -1.23M -10.27M -3.68M -4.76M -21.74M -21.49M 2.94M 1.56M 1.04M 18.3M -23.46M -16.2M
Depreciation & Amortization
n/a n/a -3.13K 13.85K 23.98K 23.58K 22.66K 32.69K 28.55K 21.77K 37.61K 7.97K 36.96K 26.46K 16.81K 34.95K 29.52K 28.67K
Stock-Based Compensation
n/a n/a 33.34K 16.46K 22.31K 236.06K 529.98K 644.62K 551.31K 557.42K 630.85K 611.46K 795.05K 596.47K 980.84K 434.98K 344.1K 1.09M
Other Working Capital
444.93K 592.67K 657.63K 273.19K 541.73K 86.3K -1.81M 168.6K 352.4K 988.18K 1.2M 362.9K -464.71K 405.69K -1.34M 1.11M -1.52M -1.33M
Other Non-Cash Items
103.62K 577.58K 3.08M -37.28K -157.18K 191.00 -5.55K 4.14M -2.81K -53.32K 17.1M 17.48M -7.41M -5.1M -5.65M -22.05M 20.47M 14.05M
Deferred Income Tax
n/a n/a -292.42K n/a n/a n/a -4.66K 2.57M -11.61K n/a -942.75K n/a 22.33K -22.33K -8.22K -5.61K -5.57K -5.4K
Change in Working Capital
491.92K 937.92K 509.78K 620.04K 826.28K -223.5K -1.48M 1.1M -2.12K 366.32K 1.99M -212.39K 84.23K 860.67K -1.4M -718.35K -1.39M -5.3M
Operating Cash Flow
-1.13M -853.72K -950.66K -223.66K 727.17K -1.03M -2.16M -1.78M -3.12M -3.87M -2.93M -3.6M -3.53M -2.07M -5.03M -4M -4.01M -6.33M
Capital Expenditures
4.00 3.00 n/a n/a n/a -3 4.00 -5 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -15.19K n/a n/a n/a
Investing Cash Flow
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -15.19K n/a n/a n/a
Debt Repayment
-350K -3.32K -327.64K -476.06K -264.91K -264.88K 697.11K -257.63K -257.73K -469.81K 880.56K -482.22K -494.34K -515.42K 1.55M -151.13K -965.6K -368.53K
Common Stock Repurchased
1M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a -8.01M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a 10.81M n/a n/a n/a n/a -294.91K n/a n/a n/a n/a n/a n/a n/a -1.12M -198.07K n/a
Financial Cash Flow
-350K -3.32K 5.04M -476.06K -264.91K -264.39K 1.47M 2.45M 2.46M -469.81K 6.4M 5.49M -494.34K -515.42K 1.55M 13.73M -228.53K 10.36M
Net Cash Flow
-1.51M -860.61K 4.39M -951.37K 470.31K -1.3M -686.72K 653.91K -637.58K -4.32M 3.38M 1.96M -4.04M -2.56M -3.46M 9.85M -4.22M 3.94M
Free Cash Flow
-1.13M -853.72K -950.66K -223.66K 727.17K -1.03M -2.16M -1.78M -3.12M -3.87M -2.93M -3.6M -3.53M -2.07M -5.03M -4M -4.01M -6.33M